In most countries, the dialysis and kidney transplant is considered as the final choices when situations develop kidney failure. But we are here to help kidney failure patients try to live a better life without dialysis and kidney transplant. However, this can be achieved? The key is to choose the appropriate treatment of renal failure.
At the hospital, and various Chinese treatments including the treatment of partial medicines Chinese herbal medicine by mouth, herbal bath and shower foot, therapy department, and so commonly used in the clinic to help patients with renal failure. It aims to repair kidney damage and restore kidney function through a series of tasks Western medicine is unable to achieve, such as the expansion of blood vessels, improve blood circulation, removing blood stasis and complexes immune to outside the body, anti-inflammation, anti-blood clotting, and the deterioration, and the advancement of DNA replication of damaged cells and promote the inherent DNA replication of damaged cells inherent. I say it simply, this is the way that help improve kidney function and then transfer the lives of patients without dialysis and kidney transplant. Each of Chinese treatments has its own method of operation, if you want more details, and welcomed to send us an kidneyhospitalabroad@hotmail.com. (In order to contact you at the appropriate time, we also suggest that you leave us the phone numbers, the WhatsApp or any other means of communication)
We have to say we can not help any patients with renal failure treatment of this disease. As a patient of kidney failure, and if the filtration rate your glomerular is between 15-59 ml / min, yes, we have the confidence to help you live a normal life without dialysis and kidney transplant, but if the filtration rate your glomerular is less than 15 ml / min , sorry, we can only help to avoid more serious consequences occur and improve the quality of life.
Showing posts with label kidney transplant. Show all posts
Showing posts with label kidney transplant. Show all posts
Sunday, November 1, 2015
Friday, April 24, 2015
Study Backs Renal Transplantation in HIV-Infected Patients
Many transplanted kidneys come from donors who have died. Some come from a living family member. The kidney was the easiest organ to transplant: tissue typing was simple, the organ was relatively easy to remove and implant, live donors could be used without difficulty, and in the event of failure, kidney dialysis was available from the 1940s. Often, the new kidney will start making urine as soon as your blood starts flowing through it. But sometimes it takes a few weeks to start working.
Renal transplantation in HIV-infected patients is associated with graft and overall survival rates similar to those of HIV-negative patients, except in cases of co-infection with hepatitis C virus (HCV), according to a new study.
The study, led by Jayme E. Locke, MD, of the University of Alabama at Birmingham, is the first national study examining outcomes among the entire U.S. cohort of HIV-positive kidney transplant recipients and comparing their outcomes to appropriately matched HIV-negative controls.
The study included 510 HIV-infected renal transplant patients and 94,948 HIV-negative controls. The 5- and 10-year graft survival among the HIV-infected patients was 68.9% and 49.5%, respectively, but was highest among those who were infected only with HIV (mono-infected) but not HCV (75% and 55.9%, respectively), Dr. Locke and colleagues reported online ahead of print in the Journal of the American Society of Nephrology. Among patients co-infected with HIV and HCV, the 5- and 10-year graft survival rates were 49.9% and 25.9%, respectively.
The researchers compared the HIV group with a matched group of HIV-negative controls. Compared with the control group, the HIV-infected patients overall had significantly lower 5- and 10-year graft survival rates (69.2% vs. 75.3% and 49.8% vs. 54.4%, respectively). The 5- and 10-year graft survival rates did not differ significantly between mono-infected HIV patients and controls (75.0% vs. 75.8% and 55.9% vs. 56.0%, respectively). The 5- and 10-year survival rates were significantly worse for patients co-infected with HIV and HCV than for matched HIV-negative controls infected with HCV (52.0% vs.64.0% and 27.0% vs. 36.2%, respectively).
Patient survival rates among all HIV-infected recipients were 83.3% and 51.5% at 5 and 10 years, respectively. The rates were higher among the mono-infected HIV patients (88.7% and 63.5%, respectively) than the co-infected patients (66.3% and 29.3%).
Additionally, compared with appropriately matched HIV-negative controls, the HIV-infected patients had similar 5-year patient survival rates (83.5% and 86.2%), but significantly lower 10-year survival rates (51.6% vs. 72.1%). The 5- and 10-year patient survival rates did not differ significantly between the mono-infected HIV patients and HIV-negative/HCV-negative controls (88.7% and 89.1% and 63.5% and 77.6%). Co-infected patients, however, had significantly worse survival at 5 and 10 years compared with HIV-negative/HCV-positive controls (67.0% vs.78.6% and 29.3% vs. 56.2%, respectively).
Renal transplantation in HIV-infected patients is associated with graft and overall survival rates similar to those of HIV-negative patients, except in cases of co-infection with hepatitis C virus (HCV), according to a new study.
The study, led by Jayme E. Locke, MD, of the University of Alabama at Birmingham, is the first national study examining outcomes among the entire U.S. cohort of HIV-positive kidney transplant recipients and comparing their outcomes to appropriately matched HIV-negative controls.
The study included 510 HIV-infected renal transplant patients and 94,948 HIV-negative controls. The 5- and 10-year graft survival among the HIV-infected patients was 68.9% and 49.5%, respectively, but was highest among those who were infected only with HIV (mono-infected) but not HCV (75% and 55.9%, respectively), Dr. Locke and colleagues reported online ahead of print in the Journal of the American Society of Nephrology. Among patients co-infected with HIV and HCV, the 5- and 10-year graft survival rates were 49.9% and 25.9%, respectively.
The researchers compared the HIV group with a matched group of HIV-negative controls. Compared with the control group, the HIV-infected patients overall had significantly lower 5- and 10-year graft survival rates (69.2% vs. 75.3% and 49.8% vs. 54.4%, respectively). The 5- and 10-year graft survival rates did not differ significantly between mono-infected HIV patients and controls (75.0% vs. 75.8% and 55.9% vs. 56.0%, respectively). The 5- and 10-year survival rates were significantly worse for patients co-infected with HIV and HCV than for matched HIV-negative controls infected with HCV (52.0% vs.64.0% and 27.0% vs. 36.2%, respectively).
Patient survival rates among all HIV-infected recipients were 83.3% and 51.5% at 5 and 10 years, respectively. The rates were higher among the mono-infected HIV patients (88.7% and 63.5%, respectively) than the co-infected patients (66.3% and 29.3%).
Additionally, compared with appropriately matched HIV-negative controls, the HIV-infected patients had similar 5-year patient survival rates (83.5% and 86.2%), but significantly lower 10-year survival rates (51.6% vs. 72.1%). The 5- and 10-year patient survival rates did not differ significantly between the mono-infected HIV patients and HIV-negative/HCV-negative controls (88.7% and 89.1% and 63.5% and 77.6%). Co-infected patients, however, had significantly worse survival at 5 and 10 years compared with HIV-negative/HCV-positive controls (67.0% vs.78.6% and 29.3% vs. 56.2%, respectively).
Older Donor Kidneys Good for Seniors
We compared graft and patient outcomes of patients on maintenance dialysis after transplantation with OLD kidneys to those receiving younger live donor (YLD) kidneys and deceased donor (DD) kidneys. Competing risks models with matched controls were used to study the independent association between older donor age and allograft survival, accounting for the competing risk of recipient mortality as well as other transplant factors. 21.6 percent), patients who received older donated kidneys were no more likely to die within a decade of transplantation than those whose kidney donors were between 50 and 59.
(HealthDay News) -- Older patients who need a kidney transplant are better off receiving an available organ from an older deceased donor rather than waiting for one from a younger donor, according to a new study published online in the Journal of the American Society of Nephrology.
While kidneys from older donors can't provide younger patients with a lifetime of kidney function, they are suitable for older people because of their shorter life expectancy, the researchers explained. Even though more than 100,000 people in the United States are waiting for a kidney transplant, most kidneys from deceased donors 65 and older are discarded, the study authors said. Making greater use of those kidneys could shorten kidney transplant waiting lists.
The researchers analyzed data from Europe and the United States. They found that people aged 60 and older who need a kidney transplant are better off getting a kidney from a deceased older donor right away, rather than waiting for an organ from a younger donor.
"Older patients derive a survival benefit from rapid transplantation with an older donor kidney, while younger patients do not derive a benefit from transplantation from an older kidney," study co-leader John Gill, M.D., of the University of British Columbia in Vancouver, Canada, said in a journal news release. "Ensuring older patients can access older donor kidneys should be a priority in the United States. This may involve increased utilization of older donor kidneys or possibly excluding younger patients from receiving these kidneys," he added. Our email is kidneyhospitalabroad@hotmail.com.
(HealthDay News) -- Older patients who need a kidney transplant are better off receiving an available organ from an older deceased donor rather than waiting for one from a younger donor, according to a new study published online in the Journal of the American Society of Nephrology.
While kidneys from older donors can't provide younger patients with a lifetime of kidney function, they are suitable for older people because of their shorter life expectancy, the researchers explained. Even though more than 100,000 people in the United States are waiting for a kidney transplant, most kidneys from deceased donors 65 and older are discarded, the study authors said. Making greater use of those kidneys could shorten kidney transplant waiting lists.
The researchers analyzed data from Europe and the United States. They found that people aged 60 and older who need a kidney transplant are better off getting a kidney from a deceased older donor right away, rather than waiting for an organ from a younger donor.
"Older patients derive a survival benefit from rapid transplantation with an older donor kidney, while younger patients do not derive a benefit from transplantation from an older kidney," study co-leader John Gill, M.D., of the University of British Columbia in Vancouver, Canada, said in a journal news release. "Ensuring older patients can access older donor kidneys should be a priority in the United States. This may involve increased utilization of older donor kidneys or possibly excluding younger patients from receiving these kidneys," he added. Our email is kidneyhospitalabroad@hotmail.com.
Saturday, December 1, 2012
High creatinine level after kidney transplant
Kidney transplant seems to be the last life-saving straw, however, it may let
kidney disease patients down. After a kidney transplant, patients have to take
the anti-rejection drugs for the rest of their life, and they may not know that
long-term use of these medicines can damage the immune system. Moreover, a
kidney transplant is such an operation that only puts a new into the body, it
doesn’t do anything to improve the abnormal immune system. 95% of the kidney
diseases are immune system disorder, now the kidney transplant can make it worse
and worse to some extent. At this time, patients are easier to get infected,
even a cold, the new immune inflammation reaction will begin, so the kidney will
be unavoidable to get damaged.
If patients find high creatinine level again, what should they do? Anyway, they don’t want to see the illness condition worsen and it develops into kidney failure and then receive another kidney transplant or undergo dialysis treatment for the rest of their life. So they should change their previous treatment.
Immunotherapy has been the most efficient treatment for kidney disease patients in 2012. it is a special treatment in our hospital, and many foreign patients say they have never seen it in other hospital. Immunotherapy contains some steps, blood purification techniques, western medicine and Chinese herbal medicine will be used in Immunotherapy. This treatment is a systemic treatment, every step aims to deal with one factor causing the kidney disease or repair the damaged kidneys, which is the reason why Immunotherapy can be efficient. As long as patients still have some certain urine, Immunotherapy may be their best choice. If you have any questions, you can leave us a message, we will give you the reply very soon.
If patients find high creatinine level again, what should they do? Anyway, they don’t want to see the illness condition worsen and it develops into kidney failure and then receive another kidney transplant or undergo dialysis treatment for the rest of their life. So they should change their previous treatment.
Immunotherapy has been the most efficient treatment for kidney disease patients in 2012. it is a special treatment in our hospital, and many foreign patients say they have never seen it in other hospital. Immunotherapy contains some steps, blood purification techniques, western medicine and Chinese herbal medicine will be used in Immunotherapy. This treatment is a systemic treatment, every step aims to deal with one factor causing the kidney disease or repair the damaged kidneys, which is the reason why Immunotherapy can be efficient. As long as patients still have some certain urine, Immunotherapy may be their best choice. If you have any questions, you can leave us a message, we will give you the reply very soon.
Monday, July 9, 2012
Dialysis and kidney transplant are not what we want
"I also feel like a horrible burden to my husband. I am so angry at God for allowing me to live with this damn disease, and I'm also angry at Him for not keeping my transplanted organs going much longer. I have friends who have had their pancreas/kidney transplants for 15 years. Couldn't have God kept my transplants going that long, as He is the creator of the universe? Other than going to heaven, I see no benefit to believing in Him. The only thing I have to say about life with type 1 diabetes is that it totally stinks, and I wouldn't wish type 1 Diabetes on my worst enemy".
after I read the words, I could not say what my feeling is exactly. as a matter of fact, dialysis and kidney transplant are not the only two ways for kidney diseases patients. if patients choose dialysis, some of them may have to suffer from the side effects caused by dialysis, the most important thing is that dialysis can not treat kidney disease, it will make the illness condition worse and worse. and the final result of dialysis must be a kidney transplant. however, donor kidneys are in short supply. patients have to wait for at least 10 years. no one can guarantee the operation will be 100% successful. there are so many cases in clinical that the kidney disease reappears after a period of time of kidney transplant.
"Micro-Chinese Medicine Osmotherapy+Immunotherapy" in Shijiazhuang Kidney Disease Hospital can help patients avoid dialysis and kidney transplant.
Thursday, May 31, 2012
after reading it, will you still wait for kidney transplant
A kidney transplant is surgery to replace your own diseased kidneys with a healthy (donor) kidney. See a picture of a kidney transplant
. There are two types of donors:
The risks of having a kidney transplant include:
· Rejectionof the new kidney.
· Severe infection.
· Bleeding.
· Reaction to the anesthesia used for surgery.
· Failure of the donor kidney
Not everyone is able to have a kidney transplant. You will not usually have a kidney transplant if you have an active infection or another life-threatening disease, such as cancer or significant heart or lung disease.
After having a kidney transplant, you will have to take medicines that suppress your immune system (immunosuppressive medicines) to help prevent your body from rejecting the new kidney. You will need to take these medicines for the rest of your life. Because these medicines weaken your immune system, you will have an increased risk for serious infections. There is also the chance that your body may still reject your new kidney even if you take these medicines. If this happens, you will have to start dialysis and possibly wait for another kidney transplant.
Subscribe to:
Posts (Atom)